Altre lingue Assembly Biosciences, Inc.

Azioni

ASMB

US0453962070

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 01/05/2024			Variaz. 5gg	Var. 1 gen.
13,27 ^USD	+6,42%		-1,56%	+34,84%

28/03	Assembly Biosciences, Inc. riporta i risultati degli utili per l'intero anno conclusosi il 31 dicembre 2023	CI
19/01	L'insider di Assembly Biosciences ha acquistato azioni per un valore di 511.264 dollari, secondo un recente deposito della SEC	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Assembly Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights	28/03
Assembly Biosciences Announces Effective Date of Reverse Stock Split	08/02
Assembly Biosciences Announces Effective Date of Reverse Stock Split	08/02
Assembly Biosciences Insider Bought Shares Worth $511,264, According to a Recent SEC Filing	19/01
Assembly Biosciences, Inc. Provides Anticipated Development Milestones for 2024	04/01
Assembly Biosciences Provides Anticipated Development Milestones for 2024	04/01
Assembly Biosciences Provides Anticipated Development Milestones for 2024	04/01
Assembly Biosciences, Inc. Appoints Tomas Cihlar to Serve on the Board	07/12
Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	10/11
Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	10/11
Assembly Biosciences Presents New Data Highlighting Viral Hepatitis Portfolio at AASLD The Liver Meeting®	10/11
Assembly Biosciences Presents New Data Highlighting Viral Hepatitis Portfolio at AASLD The Liver Meeting®	10/11
Assembly Biosciences: Q3 Earnings Snapshot	08/11
Assembly Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	08/11
Assembly Biosciences Reports Third Quarter 2023 Financial Results and Recent Updates	08/11
Assembly Biosciences Names Anuj Gaggar, MD, PhD, as Chief Medical Officer	08/11
Assembly Biosciences Names Anuj Gaggar, MD, PhD, as Chief Medical Officer	08/11
Assembly Biosciences, Inc. Appoints Anuj Gaggar as Chief Medical Officer	08/11
Nano-Cap Stock Momentum Watchlist (SING, MGRX, ICU, ASMB)	20/10/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Assembly Biosciences, Inc.

Azioni

ASMB

US0453962070

Altre lingue

Filtri